Literature DB >> 20878457

Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay.

L A Ruiz1, A Gómez, C Jaca, L Martínez, B Gómez, R Zalacain.   

Abstract

BACKGROUND: Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB.
MATERIALS AND METHODS: Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection.
RESULTS: CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay.
CONCLUSION: Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.

Entities:  

Mesh:

Year:  2010        PMID: 20878457     DOI: 10.1007/s15010-010-0058-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome.

Authors:  Rosario Menéndez; Antoni Torres; Rafael Zalacaín; Javier Aspa; Juan J Martín-Villasclaras; Luis Borderías; José M Benítez-Moya; Juan Ruiz-Manzano; Felipe Rodríguez de Castro; José Blanquer; Diego Pérez; Carmen Puzo; Fernando Sánchez-Gascón; José Gallardo; Carlos Alvarez; Luis Molinos
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

2.  [The diagnosis and treatment of community-acquired pneumonia. SEPAR. Sociedad Española de Neumología y Cirugía Torácica].

Authors:  J Dorca; S Bello; J Blanquer; R de Celis; L Molinos; A Torres; A Verano; R Zalacain
Journal:  Arch Bronconeumol       Date:  1997-05       Impact factor: 4.872

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome.

Authors:  Wah-Shing Leung; Chung-Ming Chu; Kay-Yang Tsang; Fu-Hang Lo; King-Fan Lo; Pak-Leung Ho
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

5.  Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

Authors:  R Menéndez; A Torres; R Zalacaín; J Aspa; J J Martín Villasclaras; L Borderías; J M Benítez Moya; J Ruiz-Manzano; F Rodríguez de Castro; J Blanquer; D Pérez; C Puzo; F Sánchez Gascón; J Gallardo; C Alvarez; L Molinos
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

6.  Predicting bacteremia in patients with community-acquired pneumonia.

Authors:  Mark L Metersky; Allen Ma; Dale W Bratzler; Peter M Houck
Journal:  Am J Respir Crit Care Med       Date:  2003-11-20       Impact factor: 21.405

7.  Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.

Authors:  Y Siegman-Igra; R Ravona; H Primerman; M Giladi
Journal:  Int J Infect Dis       Date:  1998 Apr-Jun       Impact factor: 3.623

8.  Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli.

Authors:  C-I Kang; J-H Song; W S Oh; K S Ko; D R Chung; K R Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-04       Impact factor: 3.267

Review 9.  [Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)].

Authors:  I Alfageme; J Aspa; S Bello; J Blanquer; R Blanquer; L Borderías; C Bravo; R de Celis; X de Gracia; J Dorca; J Gallardo; M Gallego; R Menéndez; L Molinos; C Paredes; O Rajas; J Rello; F Rodríguez de Castro; J Roig; F Sánchez-Gascón; A Torres; R Zalacaín
Journal:  Arch Bronconeumol       Date:  2005-05       Impact factor: 4.872

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  8 in total

1.  30-day mortality in UK patients with bacteraemic community-acquired pneumonia.

Authors:  M Melzer; C Welch
Journal:  Infection       Date:  2013-05-24       Impact factor: 3.553

2.  Comparison of histological lesions in mink with acute hemorrhagic pneumonia associated with Pseudomonas aeruginosa or Escherichia coli.

Authors:  Charlotte Mark Salomonsen; Mette Boye; Niels Høiby; Trine H Jensen; Anne Sofie Hammer
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

3.  Clinical characteristics and outcomes of "silent" and "non-silent" peritonitis in patients on peritoneal dialysis.

Authors:  Jie Dong; Suping Luo; Rong Xu; Yuan Chen; Ying Xu
Journal:  Perit Dial Int       Date:  2012-08-01       Impact factor: 1.756

4.  No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli.

Authors:  Josef Yayan; Beniam Ghebremedhin; Kurt Rasche
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

Review 5.  Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns.

Authors:  Catia Cilloniz; Ignacio Martin-Loeches; Carolina Garcia-Vidal; Alicia San Jose; Antoni Torres
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

Review 6.  Risk factors for community-acquired pneumonia in adults in Europe: a literature review.

Authors:  Antoni Torres; Willy E Peetermans; Giovanni Viegi; Francesco Blasi
Journal:  Thorax       Date:  2013-11       Impact factor: 9.139

Review 7.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.

Authors:  A Torres; F Blasi; W E Peetermans; G Viegi; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

8.  Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission.

Authors:  Conrad Izydorczyk; Barbara Waddell; Brett D Edwards; Jasper Greysson-Wong; Michael G Surette; Ranjani Somayaji; Harvey R Rabin; John M Conly; Deirdre L Church; Michael D Parkins
Journal:  Front Microbiol       Date:  2020-03-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.